Last reviewed · How we verify
Sterile Potassium Chloride Concentrate
Potassium chloride replaces depleted potassium ions to restore normal serum potassium levels and maintain cellular and cardiac function.
Potassium chloride replaces depleted potassium ions to restore normal serum potassium levels and maintain cellular and cardiac function. Used for Severe hypokalemia (serum potassium <2.5 mEq/L or symptomatic hypokalemia), Potassium depletion due to diuretics, diarrhea, vomiting, or other causes.
At a glance
| Generic name | Sterile Potassium Chloride Concentrate |
|---|---|
| Also known as | CAS no: 7447-40-7 |
| Sponsor | The Queen Elizabeth Hospital |
| Drug class | Electrolyte supplement / Potassium salt |
| Target | Potassium ion (K+) / Na+/K+-ATPase pump |
| Modality | Small molecule |
| Therapeutic area | Electrolyte management / Critical care |
| Phase | FDA-approved |
Mechanism of action
Potassium is an essential electrolyte critical for maintaining intracellular osmotic balance, nerve conduction, and cardiac rhythm. The concentrate form is used intravenously to rapidly correct severe hypokalemia (low blood potassium) in clinical settings where oral supplementation is insufficient or contraindicated. By restoring potassium homeostasis, it prevents life-threatening cardiac arrhythmias and muscle weakness associated with potassium deficiency.
Approved indications
- Severe hypokalemia (serum potassium <2.5 mEq/L or symptomatic hypokalemia)
- Potassium depletion due to diuretics, diarrhea, vomiting, or other causes
Common side effects
- Hyperkalemia (elevated potassium)
- Phlebitis or venous irritation at infusion site
- Cardiac arrhythmias (if infused too rapidly)
- Nausea and vomiting
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: